Retour
18
Fourchette du Jour
33,61 €
35,00 €
Fourchette 52 Semaines
28,66 €
117,33 €
Volume
1 310 662
Moyenne 50J / 200J
37,45 €
/
64,86 €
Clôture Précédente
34,64 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 35,9 | 0,4 |
| P/B | 5,5 | 2,9 |
| ROE % | 15,0 | 3,8 |
| Net Margin % | 13,1 | 3,9 |
| Rev Growth 5Y % | 20,1 | 10,0 |
| D/E | 0,0 | 0,2 |
Points Clés
Revenue grew 20,10% annually over 5 years — strong growth
Earnings declined -28,68% over the past year
ROE of 15,01% — decent returns on equity
Debt/Equity of 0,01 — conservative balance sheet
Generating 141,79M in free cash flow
P/E of 35,90 — premium valuation
Croissance
Revenue Growth (5Y)
20,10%
Revenue (1Y)12,79%
Earnings (1Y)-28,68%
FCF Growth (3Y)5,70%
Qualité
Return on Equity
15,01%
ROIC5,14%
Net Margin13,09%
Op. Margin5,88%
Sécurité
Debt / Equity
0,01
Current Ratio2,92
Interest Coverage0,00
Valorisation
P/E Ratio
35,90
P/B Ratio5,52
EV/EBITDA77,30
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12,79% | Revenue Growth (3Y) | 25,64% |
| Earnings Growth (1Y) | -28,68% | Earnings Growth (3Y) | -3,10% |
| Revenue Growth (5Y) | 20,10% | Earnings Growth (5Y) | -2,99% |
| Profitability | |||
| Revenue (TTM) | 761,41M | Net Income (TTM) | 99,65M |
| ROE | 15,01% | ROA | 11,91% |
| Gross Margin | 98,30% | Operating Margin | 5,88% |
| Net Margin | 13,09% | Free Cash Flow (TTM) | 141,79M |
| ROIC | 5,14% | FCF Growth (3Y) | 5,70% |
| Safety | |||
| Debt / Equity | 0,01 | Current Ratio | 2,92 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 35,90 | P/B Ratio | 5,52 |
| P/S Ratio | 4,70 | PEG Ratio | -1,22 |
| EV/EBITDA | 77,30 | Dividend Yield | 0,00% |
| Market Cap | 3,58B | Enterprise Value | 3,46B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 761,41M | 675,04M | 482,38M | 401,86M | 365,98M |
| Net Income | 99,65M | 139,73M | 106,14M | 101,42M | 112,51M |
| EPS (Diluted) | 0,82 | 1,23 | 0,94 | 0,87 | 0,89 |
| Gross Profit | 748,43M | 664,16M | 475,89M | 396,47M | 360,70M |
| Operating Income | 44,80M | 136,95M | 107,28M | 112,63M | 124,48M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 836,65M | 840,55M | 621,52M | 583,43M | 423,76M |
| Total Liabilities | 188,85M | 160,96M | 114,81M | 81,59M | 47,95M |
| Shareholders' Equity | 647,81M | 679,59M | 506,71M | 501,84M | 375,81M |
| Total Debt | 6,11M | 6,94M | 151 000,0 | 1,14M | 526 000,0 |
| Cash & Equivalents | 120,50M | 127,67M | 135,55M | 66,33M | 77,62M |
| Current Assets | 485,46M | 471,60M | 458,64M | 499,25M | 266,46M |
| Current Liabilities | 166,09M | 140,77M | 104,51M | 72,49M | 47,54M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#976 of 1024
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026